Skip to main content
Erschienen in: European Journal of Pediatrics 2/2015

01.02.2015 | Original Article

Viral lower respiratory tract infections and preterm infants’ healthcare utilisation

verfasst von: Simon B. Drysdale, Mireia Alcazar-Paris, Theresa Wilson, Melvyn Smith, Mark Zuckerman, Janet L. Peacock, Sebastian L. Johnston, Anne Greenough

Erschienen in: European Journal of Pediatrics | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to determine whether respiratory syncytial virus (RSV) and other viral lower respiratory tract infections (LRTI) in prematurely born infants were associated with similar effects on healthcare utilisation and related cost of care in the second compared to the first year after birth. Thirteen infants who had RSV LRTIs (RSV), 21 who had other viral LRTIs (other viral) and 25 had no viral LRTIs (no LRTI) were prospectively followed. Nasopharyngeal aspirates were collected whenever an infant had an LRTI regardless of whether it was in the hospital or in the community. Healthcare utilisation and the health-related cost of care were determined. Only the RSV group compared to the no LRTI group had higher overall respiratory costs in both year 1 (mean, £3,917 versus £24; p < 0.041) and year 2 (mean, £1,164 versus £61; p = 0.012). Only the RSV group required respiratory admissions; the RSV admission rate in year 2 was 3.4 % (number needed to treat 59). Conclusion: RSV LRTIs are associated with increased healthcare utilisation and cost of care in the first and second year; nevertheless, if prophylaxis is to be cost-effective in the second year, a high risk group needs to be identified.
Literatur
1.
Zurück zum Zitat Barber J, Thompson S (2004) Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 9:197–204PubMedCrossRef Barber J, Thompson S (2004) Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 9:197–204PubMedCrossRef
2.
Zurück zum Zitat Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JL, Bont L, Dutch RSV, Neonatal Network (2013) Respiratory syncytial virus and reucrrent wheeze in health preterm infants. N Engl J Med 368:1791–9PubMedCrossRef Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JL, Bont L, Dutch RSV, Neonatal Network (2013) Respiratory syncytial virus and reucrrent wheeze in health preterm infants. N Engl J Med 368:1791–9PubMedCrossRef
3.
Zurück zum Zitat Broughton S, Roberts A, Fox G, Pollina E, Zuckerman M, Chaudhry S, Greenough A (2005) Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants. Thorax 60:1039–44PubMedCentralPubMedCrossRef Broughton S, Roberts A, Fox G, Pollina E, Zuckerman M, Chaudhry S, Greenough A (2005) Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants. Thorax 60:1039–44PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Drysdale SB, Alcazar-Paris M, Wilson T, Smith M, Zuckerman M, Broughton S, Rafferty GF, Peacock JL, Johnston SL, Greenough A (2013) Rhinovirus infection and healthcare utilisation in prematurely born infants. Eur Respir J 42:1029–36PubMedCrossRef Drysdale SB, Alcazar-Paris M, Wilson T, Smith M, Zuckerman M, Broughton S, Rafferty GF, Peacock JL, Johnston SL, Greenough A (2013) Rhinovirus infection and healthcare utilisation in prematurely born infants. Eur Respir J 42:1029–36PubMedCrossRef
6.
Zurück zum Zitat Drysdale S, Wilson T, Alcazar M, Broughton S, Zuckerman M, Smith M, Rafferty GF, Johnston SL, Greenough A (2011) Lung function prior to viral lower respiratory tract infections in prematurely born infants. Thorax 66:468–73PubMedCrossRef Drysdale S, Wilson T, Alcazar M, Broughton S, Zuckerman M, Smith M, Rafferty GF, Johnston SL, Greenough A (2011) Lung function prior to viral lower respiratory tract infections in prematurely born infants. Thorax 66:468–73PubMedCrossRef
7.
Zurück zum Zitat Greenough A, Alexander J, Boit P, Boorman J, Burgess S, Burke A, Chetcuti PA, Cliff I, Lenney W, Lytle T, Morgan C, Raiman C, Shawn NJ, Sylvester KP, Turner J (2009) School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants. Thorax 64:490–5PubMedCrossRef Greenough A, Alexander J, Boit P, Boorman J, Burgess S, Burke A, Chetcuti PA, Cliff I, Lenney W, Lytle T, Morgan C, Raiman C, Shawn NJ, Sylvester KP, Turner J (2009) School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants. Thorax 64:490–5PubMedCrossRef
8.
Zurück zum Zitat Groothuis JR, Gutierrez KM, Lauer BA (1988) Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 82:199–203PubMed Groothuis JR, Gutierrez KM, Lauer BA (1988) Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 82:199–203PubMed
9.
Zurück zum Zitat The IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory synctyial virus monoclonal antibody reduces hospitalization from respiratory syncytial virus infection in high risk infants. Pediatrics 102:531–7CrossRef The IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory synctyial virus monoclonal antibody reduces hospitalization from respiratory syncytial virus infection in high risk infants. Pediatrics 102:531–7CrossRef
10.
Zurück zum Zitat Lanari M, Adorni F, Silvestri M, Coscia A, Musicco M: Italian Study Group on Risk Factors for RSV-Related Hospitalization (2011) The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: preliminary results. Early Hum Dev 875:S43–6 Lanari M, Adorni F, Silvestri M, Coscia A, Musicco M: Italian Study Group on Risk Factors for RSV-Related Hospitalization (2011) The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: preliminary results. Early Hum Dev 875:S43–6
11.
Zurück zum Zitat Patel DS, Paris MA, Watson F, Peacock JL, Campbell M, Greenough A (2012) RSV hospitalisation and healthcare utilisation in moderately prematurely born infants. Eur J Pediatr 171:1055–61CrossRef Patel DS, Paris MA, Watson F, Peacock JL, Campbell M, Greenough A (2012) RSV hospitalisation and healthcare utilisation in moderately prematurely born infants. Eur J Pediatr 171:1055–61CrossRef
12.
Zurück zum Zitat Royal College of Paediatrics and Child Health (2008) British National Formulary for Children (BNFC) 2008. BMJ Group, RPS Publishing, RCPCH Publications Ltd Royal College of Paediatrics and Child Health (2008) British National Formulary for Children (BNFC) 2008. BMJ Group, RPS Publishing, RCPCH Publications Ltd
13.
Zurück zum Zitat Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, Gustafsson PM (2010) Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65:1045–52PubMedCrossRef Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, Gustafsson PM (2010) Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65:1045–52PubMedCrossRef
14.
Zurück zum Zitat Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD (1999) Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354:541–5PubMedCrossRef Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD (1999) Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354:541–5PubMedCrossRef
15.
Zurück zum Zitat Thomas M, Bedford-Russell A, Sharland M (2000) Hospitalisation for RSV infection in ex-preterm infants—implications for use of RSV immune globulin. Arch Dis Child 83:122–7PubMedCentralPubMedCrossRef Thomas M, Bedford-Russell A, Sharland M (2000) Hospitalisation for RSV infection in ex-preterm infants—implications for use of RSV immune globulin. Arch Dis Child 83:122–7PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Wang EE, Law BJ, Stephens D (1995) Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 126:212–9PubMedCrossRef Wang EE, Law BJ, Stephens D (1995) Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 126:212–9PubMedCrossRef
Metadaten
Titel
Viral lower respiratory tract infections and preterm infants’ healthcare utilisation
verfasst von
Simon B. Drysdale
Mireia Alcazar-Paris
Theresa Wilson
Melvyn Smith
Mark Zuckerman
Janet L. Peacock
Sebastian L. Johnston
Anne Greenough
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 2/2015
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-014-2380-9

Weitere Artikel der Ausgabe 2/2015

European Journal of Pediatrics 2/2015 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.